SEATTLE, WA – Immunex Corporation (Nasdaq: IMNX) and Wyeth-Ayerst Laboratories, a division of American Home Products (NYSE: AHP) announced today that the U.S. Food and Drug Administration (FDA) has ...

Administration of ENBREL should be discontinued if a patient develops a serious infection. Caution should be exercised when considering the use of ENBREL in patients with a history of recurring or ...

Samsung Bioepis confirmed to Focus via email Friday that the company’s biosimilar to Amgen’s Enbrel (etanercept), to be known as Eticovo (etanercept-ykro), has been approved by the US Food and Drug ...

THOUSAND OAKS, Calif. & COLLEGEVILLE, Pa. -- Amgen and Wyeth Pharmaceuticals, a division of Wyeth, today announced updates to the U.S. Food and Drug Administration (FDA)-approved U.S. Prescribing ...

The safety of etanercept in this patient population was established through multiple pediatric trials, including a clinical study in 69 children aged 2 to 17 years with moderately to severely active ...

Oct. 14, 2004 — The U.S. Food and Drug Administration (FDA) has approved caspofungin acetate for the empiric treatment of presumed fungal infections in the setting of febrile neutropenia, etanercept ...

Sandoz has filed an antitrust lawsuit in the US against Amgen, challenging alleged anti-competitive practices surrounding the biologic blockbuster Enbrel (etanercept). Filed at the US District Court ...

Immunex Corp. is telling doctors that continued production problems could prevent it from delivering its rheumatoid arthritis drug Enbrel to the nearly 20,000 patients on its waiting list until next ...